Companies: 10,795·Total market cap: $144.5T
China Pharma Holdings, Inc.

China Pharma Holdings, Inc.

CPHIAMEXHealthcare● Active
$0.71
$-0.01(-0.82%)
Market Cap$2256873
P/E Ratio
52W High$2.05
52W Low$0.38
Overview

China Pharma Holdings, Inc. (CPHI) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CPHI · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$345,112 -44.9% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$345,112
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-44.9%
vs prior fiscal year
Latest Quarter
$168,474
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$345,112Cash on Hand
Total Debt$3.9MTotal Debt
Net Cash / Net Debt−$3.5MNet Debt Position
Cash vs Debt Ratio
Cash 8%Debt 92%

China Pharma Holdings, Inc. carries a net debt position of $3.5M. Total debt ($3.9M) exceeds cash on hand ($345,112). China Pharma Holdings, Inc. cash vs debt ratio: 8% cash / 92% debt.

Net Cash = Cash & ST Investments − Total Debt$345,112$3.9M = −$3.5M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CPHI annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$0.3M-44.9%
Dec 31, 2024$0.6M-56.0%
Dec 31, 2023$1.4M-29.9%
Dec 31, 2022$2.0M-58.2%
Dec 31, 2021$4.9M+407.4%
CPHI cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
China Pharma Holdings, Inc.
China Pharma Holdings, Inc.YOU
CPHI
$0.3M15.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

China Pharma Holdings, Inc. (CPHI) cash on hand as of December 31, 2025 is $345,112, comprising $345,112 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as China Pharma Holdings, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as China Pharma Holdings, Inc. cash reserves or cash position.

China Pharma Holdings, Inc. annual cash on hand history shows decreased -44.9% in 2025: decreased -44.9% in 2025. China Pharma Holdings, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

China Pharma Holdings, Inc. carries total debt of $3.9M against cash of $345,112, resulting in a net debt position of -$3.5M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

CPHI cash on hand · 5 questions

As of December 31, 2025, China Pharma Holdings, Inc. (CPHI) has $345,112 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $345,112 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $168,474. Data sourced from the annual 10-K filing via FMP.

CPHI cash on handCPHI cash reservesCPHI cash 2025how much cash does CPHI have

Source: FMP /balance-sheet-statement · US GAAP · China Pharma Holdings, Inc. · China Pharma Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025